Brii Biosciences
@briibio.com
We innovate and advance novel therapies to provide greater choice and freedom to broad patient populations. Brii Biosciences is a biotechnology company developing therapies to address some of the world’s most common public health challenges where patients experience high unmet medical needs, limited choice and significant social stigmas. With a focus on infectious diseases and central nervous system diseases, we have built a robust pipeline of potential treatment options based on patient insights and experiences, and are advancing these differentiated investigational therapies to address patient choice.
Brii Biosciences's Company Logos
Brii Biosciences's Brand Colors
Hex Code
Color name
RGB
HSL
CMYK
#0097E0
Cerulean
0, 151, 224
200, 100, 44
100, 33, 0, 12
#59C9FF
Malibu
89, 201, 255
200, 100, 67
65, 21, 0, 0
#015E8A
Orient
1, 94, 138
199, 99, 27
99, 32, 0, 46
About Brii Biosciences
Brii Biosciences is a biotechnology company that focuses on developing innovative therapies to address some of the world's most pressing public health challenges. Their primary goal is to provide greater options and freedom for patients who face limited choices and significant social stigmas due to high unmet medical needs. With a strong focus on infectious diseases and central nervous system diseases, Brii Biosciences has built an extensive pipeline of potential treatment options.
These therapies are developed based on deep patient insights and experiences, ensuring that they address the specific needs and preferences of patients. By advancing differentiated investigational therapies, Brii Biosciences aims to empower patients with more choices and improve their overall well-being. Their commitment to research and development is reflected in their numerous collaborations, partnerships, and clinical trials.
With their dedication to innovation and patient-centric approach, Brii Biosciences is at the forefront of revolutionizing healthcare and improving the lives of patients worldwide
Company type
Privately Held
Year founded
2018
Company size
51-200 employees
Related Brands
Tags
Biopharmaceutical development
Infectious disease therapeutics
Hepatitis B immunotherapy
HIV long-acting therapies
Central nervous system drug development
